Treffer 1 - 5 von 5 für Suche 'Ghafoori Naeeni, Farzad', Suchdauer: 0,56s Treffer weiter einschränken
  1. 1
    Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

    Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial von Solaymani-Dodaran, Masoud, Basiri, Pouria, Moradi, Milad, Gohari, Kimiya, Sheidaei, Ali, Ahi, Mohammadreza, Ghafoori Naeeni, Farzad, Ansarifar, Akram, Rahimi, Zahra, Gholami, Fatemeh, Karimi Rahjerdi, Ahmad, Hamidi Farahani, Ramin, Naderi Saffar, Kosar, Ghasemi, Soheil, Shooshtari, Ali, Honari, Mohsen, Mozafari, Ali, Khodaverdloo, Samane, Forooghizadeh, Mohsen

    Veröffentlicht in Virology journal

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial

    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial von Ahi, Mohammadreza, Hamidi Farahani, Ramin, Basiri, Pouria, Karimi Rahjerdi, Ahmad, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Gholami, Fatemeh, Moradi, Milad, Ghafoori Naeeni, Farzad, Saffar, Kosar Naderi, Ghasemi, Soheil, Barati, Babak, Moradi, Sohrab, Monazah, Arina, Pouranvari, Fatemeh, Forooghizadeh, Mohsen

    Veröffentlicht in Vaccines (Basel)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial

    Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial von Ahi, Mohammadreza, Hamidi Farahani, Ramin, Basiri, Pouria, Karimi Rahjerdi, Ahmad, Sheidaei, Ali, Gohari, Kimiya, Rahimi, Zahra, Gholami, Fatemeh, Moradi, Milad, Ghafoori Naeeni, Farzad, Saffar, Kosar Naderi, Ghasemi, Soheil, Barati, Babak, Moradi, Sohrab, Monazah, Arina, Pouranvari, Fatemeh, Forooghizadeh, Mohsen

    Veröffentlicht in Vaccines

    Volltext
    Report

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

    Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial von Solaymani-Dodaran, Masoud, Basiri, Pouria, Moradi, Milad, Gohari, Kimiya, Sheidaei, Ali, Ahi, Mohammadreza, Ghafoori Naeeni, Farzad, Ansarifar, Akram, Rahimi, Zahra, Gholami, Fatemeh, Karimi Rahjerdi, Ahmad, Hamidi Farahani, Ramin, Naderi saffar, Kosar, Ghasemi, Soheil, Shooshtari, Ali, Honari, Mohsen, Mozafari, Ali, Khodaverdloo, Samane, Forooghizadeh, Mohsen

    Veröffentlicht in Virology Journal

    Volltext
    Report

    Zu den Favoriten
    Gespeichert in:
  5. 5
    Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

    Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial von Solaymani-Dodaran, Masoud, Basiri, Pouria, Moradi, Milad, Gohari, Kimiya, Sheidaei, Ali, Ahi, Mohammadreza, Ghafoori Naeeni, Farzad, Ansarifar, Akram, Rahimi, Zahra, Gholami, Fatemeh, Karimi Rahjerdi, Ahmad, Hamidi Farahani, Ramin, Naderi saffar, Kosar, Ghasemi, Soheil, Shooshtari, Ali, Honari, Mohsen, Mozafari, Ali, Khodaverdloo, Samane, Forooghizadeh, Mohsen

    Veröffentlicht in Virology Journal

    Volltext
    Report

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: